Investor suit fueled by news articles over failed cancer drug ends in $24M settlement
Once riding high with a market value close to $1 billion, Geron on Tuesday said it settled an investor lawsuit for $24 million.
Stockholders claimed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
